Stain for CD20 showed focal weak reactivity and stain for CD5 was negative in the spindled cells. The lymphocytes showed diffuse reactivity for the T-cells markers CD3 and CD43. Furthermore ...

Ltd. announced that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “Lunsumio for intravenous infusion 1mg” and “Lunsumio for intravenous infusion 30mg” ...

Lymphocytic hypophysitis will continue to be a diagnostic and therapeutic challenge. This fascinating endocrinological disorder requires sophisticated analysis and diagnosis. With careful follow ...

日前，罗氏制药中国宣布，中国国家药品监督管理局（NMPA）正式批准皓罗华®（英文商品名：Lunsumio®，中英文通用名：莫妥珠 ...

12月23日，罗氏制药官方公众号发布罗氏又一款CD20/CD3双特异性抗体中国获批的消息。当中披露，中国国家药品监督管理局（NMPA ...

每经AI快讯，罗氏制药官微12月23日消息，罗氏制药中国宣布，中国国家药品监督管理局（NMPA）正式批准皓罗华®（英文商品名：Lunsumio®，中英文通用 ...

2024年12月23日，罗氏制药中国宣布，中国国家药品监督管理局（NMPA）正式批准皓罗华®（英文商品名：Lunsumio®，中英文通用名：莫妥珠单抗 ...